Role of mTORC1 and mTORC2 in Breast Cancer: Therapeutic Targeting of mTOR and Its Partners to Overcome Metastasis and Drug Resistance.

[1]  Jie Zhou,et al.  Delphinidin induced protective autophagy via mTOR pathway suppression and AMPK pathway activation in HER-2 positive breast cancer cells , 2018, BMC Cancer.

[2]  R. Zhou,et al.  Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway , 2018, BMC Complementary and Alternative Medicine.

[3]  J. Carroll,et al.  Combined Inhibition of mTOR and CDK4/6 Is Required for Optimal Blockade of E2F Function and Long-term Growth Inhibition in Estrogen Receptor–positive Breast Cancer , 2018, Molecular Cancer Therapeutics.

[4]  S. Coles,et al.  Synergistic effects of inhibiting the MNK-eIF4E and PI3K/AKT/ mTOR pathways on cell migration in MDA-MB-231 cells , 2018, Oncotarget.

[5]  S. Tsui,et al.  Eriocalyxin B, a novel autophagy inducer, exerts anti‐tumor activity through the suppression of Akt/mTOR/p70S6K signaling pathway in breast cancer , 2017, Biochemical pharmacology.

[6]  Tingting Lou,et al.  MicroRNA-10a suppresses breast cancer progression via PI3K/Akt/mTOR pathway , 2017, Oncology letters.

[7]  W. Muller,et al.  Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis , 2017, Breast Cancer Research.

[8]  C. Patra,et al.  Gold nanoparticles–conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt–mediated pathway in breast cancer cell lines (MCF‐7 and MDA‐MB‐231) , 2017, Cell biochemistry and function.

[9]  I. Catalá,et al.  Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition , 2016, Oncogene.

[10]  Linnan Yang,et al.  Rational Design of Multifunctional Dendritic Mesoporous Silica Nanoparticles to Load Curcumin and Enhance Efficacy for Breast Cancer Therapy. , 2016, ACS applied materials & interfaces.

[11]  M. V. Estrada,et al.  Rictor/mTORC2 Drives Progression and Therapeutic Resistance of HER2-Amplified Breast Cancers. , 2016, Cancer Research.

[12]  Hui Wang,et al.  miR‐199a‐5p regulates β1 integrin through Ets‐1 to suppress invasion in breast cancer , 2016, Cancer science.

[13]  C. Emiliani,et al.  Rapamycin Loaded Solid Lipid Nanoparticles as a New Tool to Deliver mTOR Inhibitors: Formulation and in Vitro Characterization , 2016, Nanomaterials.

[14]  Hui Wang,et al.  Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer , 2016, Oncotarget.

[15]  A. Alayev,et al.  mTORC1 directly phosphorylates and activates ERα upon estrogen stimulation , 2015, Oncogene.

[16]  Zhe Liu,et al.  MicroRNA-147 suppresses proliferation, invasion and migration through the AKT/mTOR signaling pathway in breast cancer. , 2016, Oncology letters.

[17]  S. Sahoo,et al.  Trastuzumab guided nanotheranostics: A lipid based multifunctional nanoformulation for targeted drug delivery and imaging in breast cancer therapy. , 2015, Journal of colloid and interface science.

[18]  R. Russell,et al.  MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene , 2015, Breast Cancer Research.

[19]  J. P. Sharma,et al.  Secalonic Acid-D Represses HIF1α/VEGF-Mediated Angiogenesis by Regulating the Akt/mTOR/p70S6K Signaling Cascade. , 2015, Cancer research.

[20]  Q. She,et al.  AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis , 2015, Oncotarget.

[21]  P. Frankel,et al.  Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells. , 2015, Cancer letters.

[22]  K. Nephew,et al.  microRNA regulation of mammalian target of rapamycin expression and activity controls estrogen receptor function and RAD001 sensitivity , 2014, Molecular Cancer.

[23]  M. Ferrari,et al.  Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[24]  Yonghe Li,et al.  Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells. , 2014, Cellular signalling.

[25]  R. Uzzo,et al.  Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death , 2014, British Journal of Cancer.

[26]  S. Jung,et al.  Anthricin Isolated from Anthriscus sylvestris (L.) Hoffm. Inhibits the Growth of Breast Cancer Cells by Inhibiting Akt/mTOR Signaling, and Its Apoptotic Effects Are Enhanced by Autophagy Inhibition , 2013, Evidence-based complementary and alternative medicine : eCAM.

[27]  Yifan Dai,et al.  mTORC1 is a target of nordihydroguaiaretic acid to prevent breast tumor growth in vitro and in vivo , 2012, Breast Cancer Research and Treatment.